Volume 75, Issue 9, Pages (May 2009)

Slides:



Advertisements
Similar presentations
Volume 68, Pages S24-S28 (July 2005)
Advertisements

Volume 79, Pages S3-S8 (April 2011)
Volume 67, Pages S1-S7 (June 2005)
Volume 73, Issue 1, Pages 3-5 (January 2008)
Fibroblast Growth Factor 23 and CKD Prognosis
Renal vitamin D receptor expression and vitamin D renoprotection
Anemia management in chronic kidney disease
Volume 79, Issue 9, Pages (May 2011)
Volume 83, Issue 3, Pages (March 2013)
Volume 79, Issue 9, Pages (May 2011)
FGF23 or PTH: which comes first in CKD ?
Vitamin D deficiency and heart disease
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Shining light on vitamin D trials in chronic kidney disease
FGF23–parathyroid interaction: implications in chronic kidney disease
Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets  David M. Spiegel, Kate Brady  Kidney.
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 79, Pages S3-S8 (April 2011)
M. Fukagawa, S. Nakanishi, J.J. Kazama  Kidney International 
Yasuhiro Hamada, Masafumi Fukagawa  Kidney International 
Volume 85, Issue 3, Pages (March 2014)
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Metformin and other antidiabetic agents in renal failure patients
Volume 72, Issue 6, Pages (September 2007)
Volume 66, Pages S13-S17 (September 2004)
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
The new role of calcimimetics as vasculotropic agents
Volume 70, Issue 11, Pages (December 2006)
Volume 79, Pages S20-S23 (April 2011)
Use of vitamin D in chronic kidney disease patients
Volume 87, Issue 2, Pages (February 2015)
Florian Lang, Michael Föller  Kidney International 
Volume 67, Pages S33-S36 (June 2005)
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Bisphosphonate safety and efficacy in chronic kidney disease
Volume 68, Pages S24-S28 (July 2005)
Volume 73, Issue 12, Pages (June 2008)
Volume 76, Issue 6, Pages (September 2009)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Volume 85, Issue 5, Pages (May 2014)
Volume 87, Issue 3, Pages (March 2015)
Alternate-day dialysis may be needed for hemodialysis patients
Calcium sensing in podocytes
Volume 56, Issue 4, Pages (October 1999)
Nephrology Crossword: Glomerulonephritis
Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics  William G. Goodman, L.D. Quarles 
Volume 87, Issue 5, Pages (May 2015)
Fibroblast growth factor 23: the making of a hormone
Vitamin D in chronic kidney disease: is the jury in?
Phosphate and the parathyroid
Guang-Huar Young, Vin-Cent Wu  Kidney International 
Latest findings in phosphate homeostasis
Pablo A. Ureña Torres, Marc De Broe  Kidney International 
Volume 80, Issue 10, Pages (November 2011)
Charles A. Herzog  Kidney International 
The hypothesis that abnormal BH4 metabolism impairs kidney function
Volume 75, Issue 7, Pages (April 2009)
The international realities of live donor kidney transplantation
The ins and outs of phosphate homeostasis
Cell biological and physicochemical aspects of arterial calcification
Volume 74, Issue 10, Pages (November 2008)
The Ebf1 knockout mouse and glomerular maturation
Ronen Levi, Justin Silver  Kidney International 
Volume 86, Issue 2, Pages (August 2014)
Volume 64, Pages S131-S136 (November 2003)
Presentation transcript:

Volume 75, Issue 9, Pages 880-881 (May 2009) Phosphate: despite advances in research, the benefits to patients remain limited  Marc E. De Broe  Kidney International  Volume 75, Issue 9, Pages 880-881 (May 2009) DOI: 10.1038/ki.2008.692 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Phosphorus-induced alterations in calcium and/or vitamin D metabolism change parathyroid gland function in chronic kidney disease. 1, CASR: cell suface G protein–coupled receptor of extracellular ionized Ca2+; 2, vitamin D receptor: nuclear receptor controlling gene transcription; 3, putative phosphate sensor; 4, FGF23 is a negative regulator of parathyroid function. Adapted from Quarles.3 Kidney International 2009 75, 880-881DOI: (10.1038/ki.2008.692) Copyright © 2009 International Society of Nephrology Terms and Conditions